Vice President of Health Economics and Patient Value
Jo Carol Hiatt, MD joined the Medical Device Innovation Consortium (MDIC) as Vice President, Health Economics and Patient Value (HEPV) in October 2020. Her portfolio currently includes two workstreams: Patient Perspective/Risk Tolerance Research (PPR) and Real-World Evidence (RWE). Areas of focus are close collaboration with CMS and FDA to support improved clarity around applications of RWE and PPR to inform decisions by health technology assessment organizations and payers. In June, 2021, Dr. Hiatt was elected Secretary and member of Board of Directors, Health Technology Assessment International.
Prior to MDIC, Dr. Hiatt was a physician with the Southern California Permanente Medical Group for many years. She led the Kaiser Permanente (KP) National Product Council for nearly 16 years, overseeing selection of equipment, devices, diagnostic tests, and products used to care for members across the entire program. She also chaired KP’s internal technology assessment organization. In addition, Dr. Hiatt served two terms on the Medicare Evidence Development & Coverage Advisory Committee which conducts evidence reviews and public hearings for some Medicare National Coverage decisions.
Dr. Hiatt received her undergraduate degree from Stanford University and her medical degree from Duke University. She trained in general surgery at UCLA. In addition to her clinical degree, Dr. Hiatt received an MBA from UCLA's Anderson School of Management. She has presented frequently on technology assessment integration with value-based decision and implementation processes.
Wednesday, September 29, 2021
3:45 PM – 4:45 PM ET